Table 5 Serum antibody at 6 months after SARS-CoV-2 diagnosis was correlated vaccine type. Multiple linear regression analysis was performed considering serum antibody titers at 6 months after SARS-CoV-2 diagnosis as a dependent variable. Predictors entered in the analysis were: age, gender, antibody titers at 3 months and type of vaccine
Coefficient | Standard error | t | P | 95% confidence interval | |
|---|---|---|---|---|---|
Age | 21.844 | 17.821 | 1.23 | 0.226 | −13.968 to 57.656 |
Gender | 334.568 | 414.464 | 0.81 | 0.423 | −498.329 to 1167.465 |
Antibody titers at three months from SARS-CoV-2 infection | 2.311 | 0.789 | 2.93 | 0.005 | 0.726 to 3.897 |
Type of vaccine | 3017.549 | 439.968 | 6.86 | 0.000 | 2133.400 to 3901.697 |
Cons | −3805.621 | 1131.542 | −3.36 | 0.002 | −6079.539 to −1531.702 |